<DOC>
	<DOCNO>NCT02369497</DOCNO>
	<brief_summary>This prospective study Ascension HRA device collect data assess safety effectiveness HRA .</brief_summary>
	<brief_title>Ascension® Humeral Resurfacing Arthroplasty ( HRA ) Follow-Up Study</brief_title>
	<detailed_description>This study protocol provide guidance investigator want perform non-randomized , consecutive enrollment , 10-year follow-up study patient treat Ascension® HRA . Its purpose measure document outcomes associate implant Ascension HRA prosthesis . Patients periodically assessed collect data relate safety effectiveness endpoint follow interval : preoperative , surgery/immediate post-op , 3 month , 6 month , 1 year , 2 year , 5 year , 10 year .</detailed_description>
	<criteria>Any patient treat Ascension HRA eligible inclusion study . Therefore , Principal Investigators attempt recruit patient study site treat Ascension HRA The following patient include study Patient : Is treat Ascension HRA Is disabled either noninflammatory inflammatory arthritis ( i.e . rheumatoid arthritis , osteoarthritis avascular necrosis Has mild moderate humeral head deformity /or limit motion Has posttraumatic arthritis Has intact reparable rotator cuff Has mean ability return require study visit Is willing participate study Has sign Informed Consent Form Is least 18 year age skeletally mature time surgery Is less 75 year age time surgery Infection , sepsis , osteomyelitis Osteoporosis Metabolic disorder may impair bone formation Osteomalacia Rapid joint destruction , mark bone loss bone resorption apparent Xray Revision procedure device treatment fail Refuses study ; mean ability return require study visit Currently participate another clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>